Publikationen von C. Griesinger

Carlomagno, T.; Baldus, M.; Griesinger, C.: Bio-nuclear magnetic resonance. In: Drug discovery technologies, S. 473 - 505 (Hg. Kubinyi, H.). Elsevier, Amsterdam (2007)

Carlomagno, T.; Griesinger, C.: Transferred cross-correlated relaxation: Application to drug/target complexes. In: Modern magnetic resonance. Pt. 2, S. 1229 - 1236 (Hg. Webb, G. A.). Springer, Dordrecht (2006)

Griesinger, C.; Meiler, J.; Peti, W.: Angular restraints from residual dipolar couplings for structure refinement. In: Protein NMR for the millennium, S. 163 - 229 (Hg. Krishna, R.; Berliner, L. J.). Kluwer Academic/Plenum Publ., New York (2003)

Dobrev, P.; Vemulapalli, S. P.; Nath, N.; Griesinger, C.; Grubmüller, H.: Probing the accuracy of explicit solvent constant pH molecular dynamics simulations for peptides. 64th Annual Meeting of the Biophysical-Society, San Diego, CA, 15. Februar 2020 - 19. Februar 2020. Biophysical Journal 118 (3, Suppl. 1), S. 140A - 140A (2020)

Buss, S.; Kuebler, L.; Maurer, A.; Schmidt, F.; Leonov, A.; Ryazanov, S.; Giese, A.; Griesinger, C.; Pichler, B. J.; Herfert, K.: In vitro evaluation of small molecule compounds as potential PET tracers targeting a-synuclein. 29th International Symposium on Cerebral Blood Flow, Metabolism and Function / 14th International Conference on Quantification of Brain Function with PET (BRAIN and BRAIN Pet), Yokohama, Japan, 04. Juli 2019 - 07. Juli 2019. Journal of Cerebral Blood Flow and Metabolism 39 (Suppl), S. 530 - 531 (2019)

Smith , C.; Mazur, A.; Rout, A. K.; Griesinger, C.; Lee, D.; de Groot, B.: Incorporating hierarchical kinetics into determination of protein structure. 32nd Annual Symposium of the Protein-Society, Boston, MA, 09. Juli 2018 - 12. Juli 2018. Protein Science 27 (Suppl_1), S. 158 - 159 (2018)

Antonschmidt, L.; Dervisoglu, R.; Ryazanov, S.; Leonov, A.; Wegstroth, M.; Giller, K.; Becker, S.; Lee , J.; Lal , R.; Eichele, G. et al.; Fischer , A.; Giese, A.; Andreas, L.; Griesinger, C.: The small molecule anle138b shows interaction with alpha-synuclein oligomers in phospholipid membranes. 62nd Annual Meeting of the Biophysical-Society, San Francisco, CA, 17. Februar 2018 - 21. Februar 2018. Biophysical Journal (Suppl), 3 Aufl., S. 560a - 560a (2018)

Boening, D.; Weisenburger, S.; Schomburg, B.; Giller, K.; Becker, S.; Griesinger, C.; Sandoghdar, V.: Three-dimensional angstrom resolution in fluorescence microscopy: Insight into protein structure. Conference on Lasers and Electro-Optics Europe / European Quantum Electronics Conference (CLEO/Europe-EQEC), München(Germany, 25. Juni 2017 - 29. Juni 2017. IEEE, (2017)

Sadasivam, S. M.; Ryazanov, S.; Leonov, A.; Roeters, S.; Wouterson, S.; Giese, A.; Griesinger, C.; Killian, J. A.: Effect of the novel amyloid inhibitor "anle145c" on aggregation of islet amyloid polypeptide and how it is modulated by membranes. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, 27. Februar 2016 - 02. März 2016. Biophysical Journal 110 (Suppl 1), 3 Aufl., S. 420A - 420A (2016)

Smith, C. A.; Mazur, A.; Ban, D.; Becker, S.; Griesinger, C.; Lee, D.; de Groot, B. L.: Allostery through protein motion at different length and time scales. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, 27. Februar 2016 - 02. März 2016. Biophysical Journal 110 (Suppl_1), 3 Aufl., S. 221A - 221A (2016)

Smith, C. A.; Ban, D.; Giller, K.; Becker, S.; Griesinger, C.; Lee, D.; de Groot, B.: Microsecond motion modulates ubiquitin binding through an allosteric backbone/side chain network. Biophysical Journal 108 (Supplement 1), S. 184a - 185a (2015)

Onila, I.; Fredriksson, K.; Mazur, A.; Codutti, L.; Carlomagno, T.; Möller, H. M.; Griesinger, C.; Exner, T. E.: Rational molecular design supported by ligand-based NMR techniques. 248th National Meeting of the American-Chemical-Society (ACS), San Francisco, CA, 10. August 2014 - 14. August 2014. Abstracts of Papers of the American Chemical Society 248, 447-COMP, (2014)

Prix, C.; Schmidt, F.; Levin, J.; Schinke, K.; Shi, S.; Ryazanov, S.; Leonov, A.; Högen, T.; Mitteregger-Kretzschmar, G.; Kretzschmar, H. A. et al.; Bötzel, K.; Griesinger, C.; Giese, A.: The oligomer modulator anle138b is effective in the prodromal phase of a transgenic mouse model of Parkinson's disease. Joint Congress of European Neurology, Istanbul, Turkey, 31. Mai 2014 - 03. Juni 2014. European Journal of Neurology 21 (Suppl. 1), S. 170 - 170 (2014)

Loquet, A.; Sgourakis, N.; Giller, K.; Gupta, R.; Demers, J. P.; Habenstein, B.; Riedel, D.; Goosmann, C.; Griesinger, C.; Kolbe, M. et al.; Baker, D.; Becker, S.; Lange, A.: Structure of a bacterial filament solved by solid-state NMRa: The type III secretion system needle. 9th European-Biophysical-Societies-Association Congress, Lissabon/Portugal, 13. Juli 2013 - 17. Juli 2013. European Biophysics Journal with Biophysics Letters 42 (Supplement 1), S. S204 - S204 (2013)

Smith, C. A.; Ban, D.; Peters, J. H.; Giller, K.; Becker, S.; de Groot, B. L.; Griesinger, C.; Lee, D.: Molecular recognition through concerted ubiquitin backbone and side chain motion determined from NMR and MD simulations. 57th Annual Meeting of the Biophysical-Society, Philadelphia/PA, 02. Februar 2013 - 06. Februar 2013. Biophysical Journal 104 (Supplement 1), 2 Aufl., S. 30A - 30A (2013)

Smith, C. A.; Ban, D.; Peters, J. H.; Giller, K.; Becker, S.; Groot, d.; Griesinger, C.; Lee, D.: Molecular Recognition through Concerted Ubiquitin Backbone and Side Chain Motion Determined from NMR and MD Simulations. 57th Annual Meeting of the Biophysical-Society, Philadelphia, 02. Februar 2013 - 06. Februar 2013. Biophysical Journal 104 (Supplement 1), 2 Aufl., S. 30A - 30A (2013)

Kretzschmar, H.; Wagner, J.; Ryazanov, S.; Leonov, A.; Levin, J.; Shi, S.; Prix, C.; Groschup, M.; Griesinger, C.; Giese, A.: Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation. 87th Annual Meeting of the American Association of Neuropathologists, Seattle, WA, 23. Juni 2011 - 26. Juni 2011. Journal of Neuropathology and Experimental Neurology 70 (6), S. 505 - 505 (2011)

Levin, J.; Wagner, J.; Ryazanov, S.; Leonov, A.; Shi, S.; Schmidt, F.; Prix, C.; Bertsch, U.; Mitteregger-Kretzschmar, G.; Geissen, M. et al.; Hischberger, T.; Tavan, P.; Pilger, J.; Zweckstetter, M.; Frank, T.; Baehr, M.; Weishaupt, J.; Uhr, M.; Urlaub, H.; Teichmann, U.; Boetzel, K.; Groschup, M.; Kretzschmar, H. A.; Griesinger, C.; Giese, A.: Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders 26 (Supplement 2), S. S21 - S21 (2011)

Bertoncini, C. W.; Cherny, D. I.; Fernandez, C. O.; Garfinkel, E.; Griesinger, C.; Hoyer, W.; Jares-Erijman, E. A.; Jovin, T. M.; Marsh, D.; Rasia, R. M. et al.; Roberti, M. J.; Subramaniam, V.; Zweckstetter, M.: 3D structure, ligand binding, autoinhibition, aggregation, and cellular distribution of wild-type, mutant, and labeled alpha-synuclein. Biophysical Journal 88 (1), S. 396A - 396A (2005)

Griesinger, C.: Fuzzyness of globular and aggregating proteins in neurodegeneration: an NMR spectroscopic view. In FEBS Journal, 279 (Supplement 1), S. 1 - 2. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, 04. September 2012 - 09. September 2012. (2012)